heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with Drug-Related Side Effects and Adverse Reactions in 1 studies
*Drug-Related Side Effects and Adverse Reactions: Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belica-Pacha, S; Bryszewska, M; Budryn, G; Daśko, M; Małecka, M; Miłowska, K; Oracz, J; Pałecz, B | 1 |
1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
The Interaction of Heptakis (2,6-di-O-Methyl)-β-cyclodextrin with Mianserin Hydrochloride and Its Influence on the Drug Toxicity.
Topics: Animals; beta-Cyclodextrins; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Histamine H1 Antagonists; Mianserin; Molecular Docking Simulation | 2021 |